Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (41-50 of 418) with videos related to

Pageof 42
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 29, 2011
Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelinesFilippo de Marinis, Antonio Rossi, Massimo Di Maio, et al.
Cancer Treatment Reviews|January 31, 2017
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancerConsuelo Buttigliero, Marcello Tucci, Francesca Vignani, et al.
Frontiers in Oncology|May 20, 2020
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 PandemicLucia Fratino, Giuseppe Procopio, Massimo Di Maio, et al.
Expert Review of Anticancer Therapy|August 23, 2016
Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?Maria Pia Brizzi, Daniele Pignataro, Marco Tampellini, et al.
European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.
Clinical Genitourinary Cancer|July 27, 2023
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial CancerTeresa Gamba, Jessica Paparo, Olimpia Panepinto, et al.
Clinical Lung Cancer|June 24, 2014
management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysisAntonio Passaro, Massimo Di Maio, Ester Del Signore, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2024
Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatmentsSara Notarnicola, Lucrezia Zumstein, Jessica Paparo, et al.
Tumori|August 16, 2023
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical OncologyAngioletta Lasagna, Antonella Brunello, Nicola Silvestris, et al.
Immunotherapy|November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysisSebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.
Pageof 42

Showing results (41-50 of 418) with videos related to

Sort By:
Pageof 42
Lung Cancer (Amsterdam, Netherlands)|March 29, 2011
Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelinesFilippo de Marinis, Antonio Rossi, Massimo Di Maio, et al.
Cancer Treatment Reviews|January 31, 2017
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancerConsuelo Buttigliero, Marcello Tucci, Francesca Vignani, et al.
Frontiers in Oncology|May 20, 2020
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 PandemicLucia Fratino, Giuseppe Procopio, Massimo Di Maio, et al.
Expert Review of Anticancer Therapy|August 23, 2016
Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?Maria Pia Brizzi, Daniele Pignataro, Marco Tampellini, et al.
European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.
Clinical Genitourinary Cancer|July 27, 2023
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial CancerTeresa Gamba, Jessica Paparo, Olimpia Panepinto, et al.
Clinical Lung Cancer|June 24, 2014
management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysisAntonio Passaro, Massimo Di Maio, Ester Del Signore, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2024
Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatmentsSara Notarnicola, Lucrezia Zumstein, Jessica Paparo, et al.
Tumori|August 16, 2023
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical OncologyAngioletta Lasagna, Antonella Brunello, Nicola Silvestris, et al.
Immunotherapy|November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysisSebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.
Pageof 42